Journey Medical Corporation
DERM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $79,887 | $105,019 | $33,660 | $93,162 |
| - Cash | $20,305 | $27,439 | $32,003 | $49,081 |
| + Debt | $25,705 | $17,730 | $22,965 | $9,047 |
| Enterprise Value | $85,287 | $95,310 | $24,622 | $53,128 |
| Revenue | $56,134 | $79,181 | $73,669 | $63,134 |
| % Growth | -29.1% | 7.5% | 16.7% | – |
| Gross Profit | $35,255 | $52,521 | $42,894 | $31,050 |
| % Margin | 62.8% | 66.3% | 58.2% | 49.2% |
| EBITDA | -$8,396 | $1,921 | -$23,181 | -$32,766 |
| % Margin | -15% | 2.4% | -31.5% | -51.9% |
| Net Income | -$14,672 | -$3,853 | -$29,628 | -$43,994 |
| % Margin | -26.1% | -4.9% | -40.2% | -69.7% |
| EPS Diluted | -0.72 | -0.21 | -1.69 | -2.54 |
| % Growth | -242.9% | 87.6% | 33.5% | – |
| Operating Cash Flow | -$9,127 | $5,240 | -$13,534 | -$2,181 |
| Capital Expenditures | -$15,000 | -$5,000 | -$20,000 | -$10,000 |
| Free Cash Flow | -$9,127 | $240 | -$33,534 | -$12,181 |